TUMOR-NECROSIS-FACTOR-ALPHA IS ASSOCIATED WITH DISEASE-ACTIVITY AND THE DEGREE OF ANEMIA IN PATIENTS WITH RHEUMATOID-ARTHRITIS

被引:80
作者
VREUGDENHIL, G
LOWENBERG, B
VANEIJK, HG
SWAAK, AJG
机构
[1] CATHOLIC UNIV NIJMEGEN,SINT RADBOUD HOSP,DEPT INTERNAL MED,DIV HEMATOL,NIJMEGEN,NETHERLANDS
[2] DR DANIEL DENHOED CLIN,DEPT RHEUMATOL,ROTTERDAM,NETHERLANDS
[3] UNIV HOSP DYKZIGT,DEPT HEMATOL,ROTTERDAM,NETHERLANDS
[4] ERASMUS UNIV,DEPT CHEM PATHOL,3000 DR ROTTERDAM,NETHERLANDS
关键词
ANEMIA; BFUE; ERYTHROID COLONY GROWTH; RHEUMATOID ARTHRITIS; TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA);
D O I
10.1111/j.1365-2362.1992.tb01495.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To elucidate the role of tumor necrosis factor alpha (TNF) in determining anemia of chronic disease (ACD) in rheumatoid arthritis (RA), 24 patients were studied for disease parameters, TNF serum levels and bone marrow for erythroid colony growth and compared with six controls. Serum TNF-alpha was highest in ACD and correlated well with RA disease parameters. Both TNF and other RA disease parameters correlated inversely with degree of anemia. BFUe counts were lower in ACD, correlated positively with Hb and negatively with erythrocyte sedimentation rate (ESR). TNF reduced whereas anti-TNF upregulated in vitro erythroid colony counts. TNF production occurred in similar amounts in bone marrow cultures in the three groups. From these preliminary findings we conclude that ACD in RA correlates with by RA disease activity and that TNF may serve not only as an RA disease marker but also could be one of the factors mediating impaired erythropoiesis in ACD in active RA.
引用
收藏
页码:488 / 493
页数:6
相关论文
共 42 条
[1]   MEASUREMENT OF RETICULOENDOTHELIAL IRON RELEASE USING IRON-DEXTRAN [J].
BEAMISH, MR ;
DAVIES, AG ;
EAKINS, JD ;
JACOBS, A ;
TREVETT, D .
BRITISH JOURNAL OF HAEMATOLOGY, 1971, 21 (06) :617-&
[2]   DOES ACTIVE RHEUMATOID-ARTHRITIS AFFECT INTESTINAL IRON-ABSORPTION [J].
BENN, HP ;
DREWS, J ;
RANDZIO, G ;
JENSEN, JM ;
LOFFLER, H .
ANNALS OF THE RHEUMATIC DISEASES, 1988, 47 (02) :144-149
[3]   METHOD FOR THE INVESTIGATION OF RETICULOENDOTHELIAL IRON KINETICS IN MAN [J].
BENTLEY, DP ;
CAVILL, I ;
RICKETTS, C ;
PEAKE, S .
BRITISH JOURNAL OF HAEMATOLOGY, 1979, 43 (04) :619-624
[4]   IDENTITY OF TUMOR NECROSIS FACTOR AND THE MACROPHAGE-SECRETED FACTOR CACHECTIN [J].
BEUTLER, B ;
GREENWALD, D ;
HULMES, JD ;
CHANG, M ;
PAN, YCE ;
MATHISON, J ;
ULEVITCH, R ;
CERAMI, A .
NATURE, 1985, 316 (6028) :552-554
[5]  
BEUTLER B, 1987, NEW ENGL J MED, V316, P379
[6]   THE PRESENCE OF CACHECTIN TUMOR NECROSIS FACTOR IN HUMAN-DISEASE STATES [J].
BEUTLER, B .
AMERICAN JOURNAL OF MEDICINE, 1988, 85 (03) :287-288
[7]   SERUM ERYTHROPOIETIN IN RHEUMATOID-ARTHRITIS AND OTHER INFLAMMATORY ARTHRITIDES - RELATIONSHIP TO ANEMIA AND THE EFFECT OF ANTIINFLAMMATORY TREATMENT [J].
BIRGEGARD, G ;
HALLGREN, R ;
CARO, J .
BRITISH JOURNAL OF HAEMATOLOGY, 1987, 65 (04) :479-483
[8]  
BLICK M, 1987, CANCER RES, V47, P2986
[9]  
BOT FJ, 1988, BLOOD, V71, P1609
[10]  
BROXMEYER HE, 1986, J IMMUNOL, V136, P4487